Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study of Teriparatide for Postsurgical Hypoparathyroidism
NCT01171690Phase 2Terminated
- Sponsor
- Mayo Clinic
- Start
- Nov 2010
- Primary completion
- Dec 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of teriparatide in hypoparathyroidism, sponsored by Mayo Clinic. Primary endpoint: Hospital Length of Stay at 7 days. Started Nov 2010; status: terminated.
02
Drugs
teriparatide
03
Conditions
hypoparathyroidism
Beyond the preview
Go deeper on NCT01171690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01171690.